SEC Form 4 · accession 0001209191-16-124174
Juno Therapeutics, Inc. · JUNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hyam Levitsky
Officer — EVP, Research & CSO
Period of report
May 27, 2016
Accepted (ET)
May 27, 2016 · 8:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001594864
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | May 27, 2016 | F | 16,454 | $42.04 | D | 129,118 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld by the issuer to satisfy tax withholding obligations on the vesting of restricted stock units.
- F2Includes 572 shares acquired under the issuer's employee stock purchase plan on May 16, 2016.